Prevalence of RET/PTC expression in papillary thyroid carcinoma and its correlation with prognostic factors in a north Indian population

被引:5
|
作者
Mishra, A. [1 ]
Agrawal, V [2 ]
Krishnani, N. [2 ]
Mishra, S. K. [1 ]
机构
[1] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrine Surg, Lucknow 226014, Uttar Pradesh, India
[2] Sanjay Gandhi Postgrad Inst Med Sci, Dept Pathol, Lucknow 226014, Uttar Pradesh, India
关键词
DTC; oncogene; rearranged during transfection protein; ONCOGENE ACTIVATION; PROTEIN EXPRESSION; GENE REARRANGEMENTS; RET; TUMORS; CHILDREN; LESIONS; SEARCH; CANCER;
D O I
10.4103/0022-3859.57390
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: The prevalence of Rearranged during Transfection/ Papillary Thyroid Carcinoma (RET/PTC) rearrangement in papillary thyroid carcinoma (PTC) varies in different geographic regions and its prognostic significance remains unclear. Aim: The aim of this study was to recognize the prevalence of RET/PTC expression in PTC from the endemically iodine-deficient region in Northern India and to correlate the expression with the clinicopathologic prognostic factors. Settings and Design: Retrospective. Archival tissue used. Materials and Methods: Immunohistochemistry was performed to look for activated RET protein expression in 50 cases of PTC. No patient had any history of prior irradiation. Statistical Analysis Used: Chi-square method, Student t test, and binary regression method. A P value of <.05 was considered significant for all the tests. Results: The prevalence of RET expression was 44%. Twenty-six (52%) cases showed RET immunoreactivity in histiocytes. Immunoreactivity was the highest in the classic variant of PTC (47.5%), followed by tumors with poorly differentiated areas (25%) and follicular variant (16.7%). RET expression was more prevalent in young patients (45.5 vs. 35.3%), females (43.3 vs. 40.0%), small tumors (33.3 vs. 26.7%), multicentric tumors (36.8 vs. 33.3%), tumors with extrathyroidal invasion (38.9 vs. 32.4%), and regional lymphadenopathy (55.2 vs. 22.2%), while it was less in cases with distant metastases (20 vs. 43.9%). There was no significant correlation of immunoreactivity with any prognostic factor. However, when the cases having immunoreactivity within histiocytes (n = 26) and histiocytes + tumor tissue (n = 28) were considered, then the expression was significantly more in cases with lymphadenopathy (P values =.009, in both instances). However, the exact clinical significance of RET/PTC positive histiocytes remained unexplained. Conclusions: Prevalence of RET/PTC in our study was consistent with the reported prevalence from other geographic areas. There was no significant correlation with the clinicopathologic factors. However, uniform techniques of detection and large international collaborative studies could clear the uncertainties regarding the prognostic importance of RET/PTC.
引用
下载
收藏
页码:171 / 175
页数:5
相关论文
共 50 条
  • [41] RET Oncogene Expression of Papillary Thyroid Carcinoma in Korea
    Ki-Wook Chung
    Myung Chul Chang
    Dong-Young Noh
    Seung Keun Oh
    Kuk Jin Choe
    Yeo-Kyu Youn
    Surgery Today, 2004, 34 : 485 - 492
  • [42] RET oncogene expression of papillary thyroid carcinoma in Korea
    Chung, KW
    Chang, MC
    Noh, DY
    Oh, SK
    Choe, KJ
    Youn, YK
    SURGERY TODAY, 2004, 34 (06) : 485 - 492
  • [43] PROGNOSTIC FACTORS IN PAPILLARY CARCINOMA OF THE THYROID
    SCHINDLER, AM
    VANMELLE, G
    EVEQUOZ, B
    SCAZZIGA, B
    CANCER, 1991, 68 (02) : 324 - 330
  • [44] Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese
    Liu, RT
    Chou, FF
    Wang, CH
    Lin, CL
    Chao, FP
    Chung, JC
    Huang, CC
    Wang, PW
    Cheng, JT
    THYROID, 2005, 15 (04) : 326 - 335
  • [45] The correlation analysis of RET gene polymorphism with papillary thyroid carcinoma
    Wang, Dong-Guo
    Chen, Jia-Yu
    Zhang, Hua-Yuan
    Zhang, Fang-Fang
    Yang, Lin-Jun
    Mu, Yong-Hua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (10): : 10707 - 10713
  • [46] Histomorphologic and clinical correlation of RET expression in papillary thyroid carcinomas
    Herrmann, ME
    Wojcik, EM
    Husain, AN
    Martinez, B
    Bakhos, R
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 112 (04) : 537 - 537
  • [47] The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults
    Fenton, CL
    Lukes, Y
    Nicholson, D
    Dinauer, CA
    Francis, GL
    Tuttle, RM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03): : 1170 - 1175
  • [48] Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure
    Fischer, AH
    Bond, JA
    Taysavang, P
    Battles, OE
    Wynford-Thomas, D
    AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (05): : 1443 - 1450
  • [49] Association of different ret/PTC rearrangements with behavior and morphology of pediatric papillary thyroid carcinoma
    Nikiforov, YE
    Fagin, JA
    Biddinger, P
    MODERN PATHOLOGY, 1998, 11 (01) : 58A - 58A
  • [50] Concomitant RAS, RET/PTC, or BRAF Mutations in Advanced Stage of Papillary Thyroid Carcinoma
    Zou, Minjing
    Baitei, Essa Y.
    Alzahrani, Ali S.
    BinHumaid, Faisal S.
    Alkhafaji, Dania
    Al-Rijjal, Roua A.
    Meyer, Brian F.
    Shi, Yufei
    THYROID, 2014, 24 (08) : 1256 - 1266